March 26, 2018 / 6:39 AM / a month ago

BRIEF-Reneuron Group Says Initial Cancer Clinical Trial Application Planned For 2019

March 26 (Reuters) - Reneuron Group Plc:

* RENEURON GROUP PLC - PHASE I/II STUDY TO BE EXPANDED TO TARGET PATIENTS WITH LESS IMPAIRED VISION AHEAD OF FUTURE PHASE IIB STUDY

* RENEURON GROUP PLC - TOP LINE PHASE I/II DATA NOW EXPECTED IN H1 2019

* RENEURON GROUP PLC - INITIAL CLINICAL TRIAL APPLICATION PLANNED FOR 2019 IN CANCER

* RENEURON GROUP PLC - EXPECT SHORT TERM READ-OUTS FROM ONGOING PHASE I/II CLINICAL TRIAL LATER THAN ORIGINALLY PLANNED, IN FIRST HALF OF 2019 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below